CIK 0001847367 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 4 Other disposition 10% owner disposed of 2,299,807 shares (other)
- 4 Other disposition 10% owner disposed of 2,299,807 shares (other)
- 4 Other disposition Director disposed of 2,299,807 shares (other)
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 588,235 shares at $17.00 ($9,999,995)
- 4 Open-market buy 10% owner bought 411,764 shares at $17.00 ($6,999,988)
- 4 Open-market buy 10% owner bought 411,764 shares at $17.00 ($6,999,988)
- 4 Open-market buy Director bought 411,764 shares at $17.00 ($6,999,988)
- 4 Open-market buy Director bought 186,377 shares at an average $9.84 ($1,833,760)
- 4 Open-market buy Director bought 262,027 shares at an average $7.79 ($2,039,901)
- 4 Open-market buy Director bought 173,589 shares at an average $7.55 ($1,310,677)
- 4 Open-market buy 10% owner bought 72,212 shares at $7.38 ($532,925)
- 4 Open-market buy Director bought 72,212 shares at $7.38 ($532,925)
Page 2 of 6 · 114 filings